Detalhe da pesquisa
1.
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse.
Blood
; 140(11): 1305-1321, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820057